Market Size of Dental Biomaterials Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 6.80 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Dental Biomaterials Market Analysis
The dental biomaterials market is expected to register a CAGR of 6.8% over the forecast period.
The impact of the COVID-19 pandemic on the market was significant as several elective procedures, including dental treatments, were halted or postponed during the pandemic. In March 2020, the American Dental Association (ADA) recommended postponing all elective dental procedures until April 6, 2020, and providing emergency-only dental services to keep patients from burdening hospital emergency departments. This recommendation was updated on April 1, 2020, when the ADA advised offices to remain closed except for urgent and emergency procedures until April 30, owing to the rising cases of COVID-19. As a result, access to dental care substantially decreased. Furthermore, as per data published by the British Dental Association, in July 2021, out of 2,053 dentists, only 36.0% were ready to resume dental practices in the United Kingdom. During the initial phase of the pandemic, dental services and treatments were delayed, which resulted in decreased demand for dental biomaterials and adversely impacted the market. However, with the resumption of dental services and with the decrease in the cases of COVID-19, the market started to gain traction and is expected to continue to grow over the forecast period.
The increasing burden of dental disorders and growing dental tourism, increasing penetration of dental implants, and increasing disposable income across developing countries are the major drivers for the market. The growing burden of dental diseases such as periodontal disease, tooth decay, oral cancer, halitosis, and dental caries, among other diseases, is driving the market growth. For instance, as per a March 2021 update by the WHO, it is estimated that oral diseases affect nearly 3.5 billion people globally, especially severe periodontal (gum) disease. Furthermore, according to a research article published in Dentaly.org in December 2021, the dental implant tourism is a growing business attributed to cost savings. Therefore, such a scenario may increase the demand for dental biomaterials owing to which considerable market growth is expected over the forecast period.
Furthermore, as per a March 2022 update by the WHO, severe periodontal (gum) disease, which may result in tooth loss, is also prevalent, affecting almost 10.0% of the global population. Adding to that, as per the NHS Dental Statistics for England 2021 report, 18.2 million adults were seen by an NHS Dentist in the 24 months up to June 2021. In addition, as per the same source, 3.9 million children were seen by an NHS dentist in the 12 months up to June 2021. Moreover, increasing product launches by the key players are also surging the market growth. For instance, in May 2021, Botiss launched a next generation dental biomaterial, NOVAMag regeneration system. The product provides an option for those dentists seeking a biomaterial that is mechanically strong but completely resorbable and is replaced with bone over time. Thus, the increasing prevalence of dental diseases and product launches by the key players may create opportunities for the market owing to which considerable market growth is expected over the forecast period.
However, regulatory issues and high cost of procedures may restrain the market growth over the forecast period.
